NCT03893487 2025-07-11PNOC016University of California, San FranciscoPhase EARLY_PHASE1 Active not recruiting30 enrolled
NCT01742988 2021-05-06Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With LymphomaCuris, Inc.Phase 1 Completed106 enrolled